Question 1

Has Christopher Defilippi received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $9,152,611 in general payments to Christopher Defilippi across 422 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Christopher Defilippi did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Christopher Defilippi come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Regeneron	24	$2,552,644
Abbott	180	$2,490,875
Ortho-clinical Diagnostics, Inc.	54	$1,281,744
Roche Diagnostics Corporation	16	$1,132,188
Roche Molecular Systems, Inc.	23	$637,706
Siemens Medical Solutions USA, Inc.	39	$634,469
CSL Behring	52	$281,642
Roche Diagnostics Operations, Inc.	2	$87,782
Quidel Corporation	5	$19,874
Amgen	13	$12,338
Fujirebio Diagnostics, Incorporated	2	$9,060
Roche Diagnostics International Ltd	2	$6,033
Polymedco, LLC	3	$5,300
Lumiradx, Inc.	1	$300
Philips North America LLC	2	$300
AstraZeneca	2	$199
Kestra Medical Technology Services, Inc.	1	$100
Novo Nordisk	1	$57

Christopher Defilippi

Payments from drug & device makers

Who reported the general payments

How this compares

Other cardiovascular disease in Baltimore